SEC Form 4 · accession 0001144204-17-042324
Prestige Consumer Healthcare Inc. · PBH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean A Boyko
Officer — SVP, Science and Technology
Period of report
Aug 9, 2017
Accepted (ET)
Aug 11, 2017 · 12:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001295947
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 per share | Aug 9, 2017 | M | 12,876 | $13.24 | A | 26,566 | D | |
| Common Stock, par value $0.01 per shareF1 | Aug 9, 2017 | S | 12,876 | $52.12 | D | 13,690 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (rights to buy)F2 | $13.24 | Aug 9, 2017 | M | 12,876 | D | — | May 9, 2022 | Common Stock | 12,876 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $52.00 to $52.31. The price reported above reflects the weighted average sale [or purchase] price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2The options vested in three installments as followed: 8,839 on May 9, 2013 and 8,838 each on May 9, 2014 and 2015.